Various peroxisome proliferator-activated receptor (PPAR)-γ agonists differently induce differentiation of cultured human keratinocytes

Experimental Dermatology

Volumn 24, Issue 1, 2015, Pages 62-65

  Yan, Yan ^a,b   Furumura, Minao ^a   Numata, Sanae ^a   Teye, Kwesi ^a   Karashima, Tadashi ^a   Ohyama, Bungo ^a   Tanida, Norifumi ^c   Hashimoto, Takashi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c HISAMITSU PHARMACEUTICAL CO INC   (Japan)

Author keywords

Filaggrin; Keratinocyte; Loricrin; Peroxisome proliferator activated receptors; Thiazolidinedione

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 2,4-THIAZOLIDINEDIONE; ANTIINFLAMMATORY AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CHROMAN DERIVATIVE; CIGLITAZONE; FILAGGRIN; INTERMEDIATE FILAMENT PROTEIN; LORICRIN; MEMBRANE PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE; TELMISARTAN; TROGLITAZONE;

AGONISTS; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; HUMAN; KERATINOCYTE; METABOLISM; SKIN;

ANTI-INFLAMMATORY AGENTS; BENZIMIDAZOLES; BENZOATES; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMANS; GENE EXPRESSION REGULATION; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATINOCYTES; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; PPAR GAMMA; RNA, MESSENGER; SKIN; THIAZOLIDINEDIONES;

EID: 84920481907     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12571     Document Type: Article

References (25)

1. Varga T, Czimmerer Z, Nagy L. Biochim Biophys Acta 2011: 1812: 1007-1022.
2. Schmuth M, Haqq C M, Cairns W J et al. J Invest Dermatol 2004: 122: 971-983.
3. Schmuth M, Moosbrugger-Martinz V, Blunder S et al. Biochim Biophys Acta 2014: 1841: 463-473.
4. Nakai K, Yoneda K, Haba R et al. Exp Dermatol 2013: 22: 772-774.
5. Berger J, Moller D E. Annu Rev Med 2002: 53: 409-435.
6. Villacorta L, Schopfer F J, Zhang J et al. Clin Sci (Lond) 2009: 116: 205-218.
7. Giorgino F, Leonardini A, Laviola L. Ann N Y Acad Sci 2013: 1281: 36-50.
8. Mao-Qiang M, Fowler A J, Schmuth M et al. J Invest Dermatol 2004: 123: 305-312.
9. Demerjian M, Man M Q, Choi E H et al. Exp Dermatol 2006: 15: 154-160.
10. Bhagavathula N, Nerusu K C, Lal A et al. J Invest Dermatol 2004: 122: 130-139.
11. Mori H, Okada Y, Arao T et al. Adv Ther 2012: 29: 635-644.
12. Kurtz T W. Acta Diabetol 2005: 42(Suppl 1): S9-S16.
13. Amano Y, Yamaguchi T, Ohno K et al. Hypertens Res 2012: 35: 715-719.
14. Westergaard M, Henningsen J, Svendsen M L et al. J Invest Dermatol 2001: 116: 702-712.
15. Wei S, Yang J, Lee S L et al. Cancer Lett 2009: 276: 119-124.
16. He G, Thuillier P, Fischer S M. J Invest Dermatol 2004: 123: 1110-1119.
17. Saha A K, Persons K, Safer J D et al. Biochem Biophys Res Commun 2006: 349: 519-524.
18. Devgan V, Nguyen B C, Oh H et al. J Biol Chem 2006: 281: 30463-30470.
19. Koster M I, Roop D R. J Dermatol Sci 2004: 34: 3-9.
20. Di Cunto F, Topley G, Calautti E et al. Science 1998: 280: 1069-1072.
21. McDade S S, Patel D, McCance D J. J Cell Sci 2011: 124: 1635-1643.
22. Willson T M, Brown P J, Sternbach D D et al. J Med Chem 2000: 43: 527-550.
23. Nemenoff R A. J Thorac Oncol 2007: 2: 989-992.
24. Gijsbers L, Man H Y, Kloet S K et al. Anal Biochem 2011: 414: 77-83.
25. Feinstein D L, Spagnolo A, Akar C et al. Biochem Pharmacol 2005: 70: 177-188.